Autolus Therapeutics PLC
0.12 (6.38%)
Upgrade to Real-Time
Afterhours (Closed)
Volume 655,422
Bid Price 1.89
Ask Price 2.00
News -
Company Name Stock Ticker Symbol Market Type
Autolus Therapeutics PLC AUTL NASDAQ Depository Receipt
  Price Change Change Percent Stock Price Last Traded
0.12 6.38% 2.00 19:03:15
Open Price Low Price High Price Close Price Prev Close
1.94 1.83 2.01 1.99 1.88
Trades Volume VWAP Dollar Volume Avg Volume
3,544 655,422  1.91  1,252,039 -
Last Trade Time Type Quantity Stock Price Currency
19:12:24 formt 400  2.00 USD


Draw Mode:

Autolus Therapeutics PLC Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
 346.12M 173.06M 173.06M  2.60M  - -1.98 -1.00
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
-  - - - -

more financials information »

News Autolus Therapeutics

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

AUTL Historical

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week0.
1 Month0.
3 Months0.
6 Months0.
1 Year0.
3 Years0.
5 Years0.

Autolus Therapeutics PLC is a biopharmaceutical company developing next-generation programmed T cell therapies for the treatment of cancer. The company's clinical-stage pipeline comprises Obe-cel (obecabtagene autoleucel), AUTO1/22, AUTO3, AUTO5, AUTO6, AUTO7 & AUTO8.